SCHEMBL23095068

SCHEMBL23095068

c1cncc(-c2ccc(-c3ccc(-c4cc(-c5cccc6ccccc56)nc(-c5cc6ccccc6c6ccccc56)n4)cc3)cc2)c1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 5/20 0.58
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
DHODH Q02127 1/20 0.46
CYP11B2 P19099 4/20 0.43
CYP19A1 P11511 2/20 0.43
CYP17A1 P05093 1/20 0.43
GPR84 Q9NQS5 1/20 0.41
CYP2C9 P11712 2/20 0.40
TNF P01375 1/20 0.40
USP1 O94782 5/20 0.39
WDR48 Q8TAF3 5/20 0.39
BCHE P06276 1/20 0.38
CYP2A6 P11509 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21725388 0.93 CYP11B1 (0.59) CYP11B1KDM4EALDH1A1MAPTHPGD
SCHEMBL19638082 0.92 CYP11B1 (0.64) CYP11B1KDM4EALDH1A1MAPTHPGD
SCHEMBL23095072 0.92 ALDH1A1 (0.53) CYP11B1KDM4EALDH1A1MAPTHPGD
SCHEMBL19650543 0.92 CYP11B1 (0.58) CYP11B1KDM4EALDH1A1MAPTHPGD
SCHEMBL21725403 0.91 CYP11B1 (0.66) CYP11B1KDM4EALDH1A1MAPTHPGD
SCHEMBL19638272 0.91 CYP11B1 (0.66) CYP11B1KDM4EALDH1A1MAPTHPGD
SCHEMBL23095081 0.91 CYP11B1 (0.56) CYP11B1KDM4EALDH1A1MAPTHPGD
SCHEMBL17918130 0.91 CYP11B1 (0.56) CYP11B1KDM4EALDH1A1MAPTHPGD
SCHEMBL21725411 0.90 CYP11B1 (0.54) CYP11B1KDM4EALDH1A1MAPTHPGD
SCHEMBL17918047 0.89 CYP11B1 (0.60) CYP11B1KDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10950797-B2 Organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2021-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10950797-B2 Organic electroluminescent device SLC29A2, SLC29A1, NUDT1 CYP11B1 1493/4885KDM4E 1386/4885ALDH1A1 427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.